COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer (STEM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02970682
Recruitment Status : Completed
First Posted : November 22, 2016
Last Update Posted : July 12, 2019
Premier Research Group plc
Information provided by (Responsible Party):
Evgen Pharma

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 2019
Actual Study Completion Date : March 2019